OBJECTIVE: Compare ultrasound (US) assignment of chorionicity with single nucleotide polymorphism (SNP)-based NIPT that determines zygosity using a proprietary algorithm. STUDY DESIGN: Twin samples collected between October 2017 and May 2018 were analyzed by SNP-based NIPT for zygosity (dizygous [DZ] or monozygous [MZ]). Data collected included chorionicity reported by the ordering provider (i.e., monochorionic [MC], dichorionic [DC], "don't know", or unspecified [field left blank]) and gestational age (GA) at time of blood draw. Provider-assigned chorionicity was correlated with SNP-based NIPT zygosity determination. RESULTS: A total of 4,885 twins received SNP-based NIPT zygosity determination; average GA was 13 weeks 3 days. Chorionicity was recorded for 3,949 (80.8%) twins: MC (n¼553 [11.3%]), DC (n¼2,330 [47.7%]), and "don't know" (n¼1,066 [21.8%]). The proportion of MZ and DZ twins was 29.7% and 70.3%, respectively. In a total 41.0% of twins, chorionicity was either "don't know" or unspecified; of those, 30.7% were identified as MZ. Of twins identified as MC, 3.4% were found to be DZ; 12.9% of DC twins were MZ (Table 1) . CONCLUSION: This is the first large cohort of twins for which NIPTbased zygosity was correlated with provider-assigned chorionicity. The proportion of MZ/DZ twins determined by SNP-based NIPT was in line with expectations (30%/70%). Almost half of twins with unspecified chorionicity were identified as MZ, for whom early/accurate chorionicity assignment is critical to assess risk for adverse outcomes. The 3.4% discordance between "MC" cases identified by NIPT as DZ, which are at extremely low risk for twin-twin transfusion syndrome, suggests that NIPT may reduce cost of care and limit surveillance for select twins. Conversely, DC twins identified as MZ may benefit from reevaluated chorionicity given the severity of complications associated with MC twins and literature suggesting that up to 19% of MC twins are misdiagnosed; cases with confirmed DC/MZ twins could be counseled as having no more than average maternal age-related risk for aneuploidy. Taken together, these data demonstrate that zygosity assignment by SNP-based NIPT can identify a substantial proportion of twins where accurate chorionicity assignment is expected to have important impact on the course of patient care/ counseling and outcome.
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918 Variable phenotypic presentation of PLD1 associated congenial heart disease in a set of identical triplets ventricular septal defect, atrial septal defect, and bilateral superior vena cava without evidence of bridge; infant C: functional single ventricle (tricuspid atresia, absent pulmonary valve, right ventricle hypoplasia due to right ventricular septal mass, left ventricle non compaction cardiomyopathy), dual atrioventricular node physiology, and multi-factorial pulmonary hypertension. Postnatal aCGH and NGS were performed on all family members. This allowed for the detection of compound heterozygous changes in the PLD1 gene in all three of the infants. The mother was heterozygous for the missense mutation, c.3142C>G on chromosome 3 in the region of the PLD1 gene. The father was heterozygous for a partial duplication of exon 12-19 in the PLD1 gene. All three infants were found to have compound heterozygous mutations of PLD1, including a partial duplication and a missense mutation. CONCLUSION: While PLD1 pathogenic variants have been associated with cardiac changes mainly in the valves, this report shows that the same genetic changes in identical siblings can have a dramatic variation in phenotype. It also reveals a new association between left ventricular non-compaction and the PLD1 gene.
919 Impact of introduction of NIPT on uptake of genetic testing in fetuses with CNS anomalies. OBJECTIVE: Fetal central nervous system (CNS) anomalies are often associated with genetic anomalies and further genetic testing is therefore recommended. Cell-free fetal DNA screening (NIPT) has decreased the uptake of invasive testing. NIPT is however not recommended in the presence of major fetal anomalies as it will fail to detect pathogenic microscopic and sub-microscopic chromosomal anomalies. The aim of our study was to assess whether introduction of NIPT has changed genetic testing strategies in pregnancies complicated by fetal CNS anomalies. STUDY DESIGN: Retrospective review of all singleton pregnancies complicated by fetal CNS anomalies seen at a single tertiary center
